Charles River Laboratories
Lynsey Macleod possesses extensive experience in the pharmaceutical and healthcare sectors, currently serving as an Account Manager Executive at Charles River Laboratories since January 2021, after progressing through various roles within the company. Prior to this, Lynsey held positions at AstraZeneca, focusing on diabetes care within the NHS across multiple regions from February 2017 to October 2020. Additional experience includes roles at LEO Pharma, Johnson & Johnson Diabetes Care Companies, Boehringer Ingelheim Pharmaceuticals, Merck Sharp & Dohme, and Schering-Plough Research Institute, with a strong emphasis on diabetes, dermatology, and respiratory conditions. Lynsey earned a BSc in Biomedical Sciences from Edinburgh Napier University between 1994 and 1998.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.